Influenza virus split vaccine: Clinical Trials

3 trials of Influenza virus split vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow Influenza virus split vaccine: new trials by email Literature Review of Influenza virus split vaccine trials Research Report on Influenza virus split vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
Influenza virus split vaccine (0.7mL/vial), Influenza virus split vaccine - Influenza
Phase 2Not yet recruitingShanghai Institute Of Biological Products12002026-01-072026-01-15
A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
Influenza virus split vaccine (0.7mL/vial), Influenza virus split vaccine, Phosphate buffer solution (PBS) - Influenza
Phase 1RecruitingShanghai Institute Of Biological Products1202025-12-162026-01-14
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
quadrivalent influenza split vaccine, Influenza virus split vaccine - Influenza
Phase 1CompletedJiangsu Province Centers for Disease Control and Prevention1202021-10-262022-10-28

Conditions studied

Influenza, Human (3)

Sponsors

Shanghai Institute Of Biological Products (2)  ·  Jiangsu Province Centers for Disease Control and Prevention (1)

Countries

China (3)

Top investigators

Yeqing Tong (1)